CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER

作者: H.G. WIENER , CH. MIAN , A. HAITEL , A. PYCHA , G. SCHATZL

DOI: 10.1016/S0022-5347(01)63184-7

关键词: Bladder cancerPathologyCytologyUrineDiagnostic testPredictive value of testsMedicineUrinary bladderCancerCystoscopyNuclear medicine

摘要: AbstractPurpose: We compare the diagnostic value of NMP22 [dagger] and BTA stat [double dagger] testing, QUANTICYT [section] computer assisted dual parameter image analysis to cytology cystoscopy in patients who had symptoms suggestive transitional cell cancer or were being followed after treatment for that disease.[dagger] Matritech, Inc., Newton, Massachusetts.[double Bard Diagnostics, Redmond, Washington.[section] Gentian Scientific Software, Niawier, The Netherlands.Materials Methods: prospectively evaluated voided urine and/or barbotage specimens from 291 a mean 65.2 years old. All samples by quick staining standard cytology, 1-step qualitative assay (which detects bladder tumor associated antigen) test nuclear mitotic apparatus protein). In addition, analysis. underwent subsequent cystos...

参考文章(12)
E.C.M. Ooms, P.H.J. Kurver, R.W. Veldhuizen, C.L. Alons, Mathilde E. Boon, Morphometric grading of bladder tumors in comparison with histologic grading by pathologists. Human Pathology. ,vol. 14, pp. 144- 150 ,(1983) , 10.1016/S0046-8177(83)80243-3
E.C.M. Ooms, W.A.D. Anderson, C.L. Alons, Mathilde E. Boon, R.W. Veldhuizen, Analysis of the performance of pathologists in the grading of bladder tumors Human Pathology. ,vol. 14, pp. 140- 143 ,(1983) , 10.1016/S0046-8177(83)80242-1
Mark S. Soloway, Joseph V. Briggman, Gennaro A. Carpinito, Gerald W. Chodak, Paul A. Church, Donald L. Lamm, Paul Lange, Edward Messing, Robert M. Pasciak, George B. Reservitz, Daniel B. Rukstalis, Michael F. Sarosdy, Walter M. Stadler, Robert P. Thiel, Cheryl L. Hayden, Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment The Journal of Urology. ,vol. 156, pp. 363- 367 ,(1996) , 10.1016/S0022-5347(01)65851-8
M. F.* Sarosdy, R.W. deVere White, M.S. Soloway, J. Sheinfeld, M.A. Hudson, P.F. Schellhammer, M.V. Jarowenko, G. Adams, B.A. Blumenstein, Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder Cancer The Journal of Urology. ,vol. 154, pp. 379- 384 ,(1995) , 10.1016/S0022-5347(01)67054-X
R E Banks, W H Porter, P Whelan, P H Smith, P J Selby, Soluble forms of the adhesion molecule E-cadherin in urine. Journal of Clinical Pathology. ,vol. 48, pp. 179- 180 ,(1995) , 10.1136/JCP.48.2.179
H.G. Van Der Poel, J.A. Witjes, P. Van Stratum, M.E. Boon, F.M.J. Debruyne, J.A. Schalken, Quanticyt karyometric analysis of bladder washing for patients with superficial bladder cancer Urology. ,vol. 48, pp. 357- 364 ,(1996) , 10.1016/S0090-4295(96)00210-5
Marie-Ange D'Hallewin, Luc Baert, Initial evaluation of the bladder tumor antigen test in superficial bladder cancer The Journal of Urology. ,vol. 155, pp. 475- 476 ,(1996) , 10.1016/S0022-5347(01)66422-X
Naoto Miyanaga, Hideyuki Akaza, Satoru Ishikawa, Mikinobu Ohlani, Ryosuke Noguchi, Koji Kawai, Kenkichi Koiso, Masaki Kobayashi, Akio Koyama, Takenori Takahashi, Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer. European Urology. ,vol. 31, pp. 163- 168 ,(1997) , 10.1159/000474443
Derek Raghavan, William U. Shipley, Marc B. Garnick, Pamela J. Russell, Jerome P. Richie, Biology and Management of Bladder Cancer The New England Journal of Medicine. ,vol. 322, pp. 1129- 1138 ,(1990) , 10.1056/NEJM199004193221607